With their own brands tarnished by legal problems, Acadia and UHS are piggybacking off nonprofit hospitals' strong local reputations.
 Andrew Spear for STAT
Troubled for-profit chains are stealthily operating dozens of psychiatric hospitals under nonprofits' names Dozens of nonprofits are turning to investor-owned psychiatric hospital operators — particularly the two biggest, Acadia and Universal Health Services — to build new hospitals to manage the surging number of people experiencing mental health emergencies. These joint ventures are appealing for Acadia and UHS, too, because they can piggyback off the nonprofits' strong local reputations — the "brand halo effect," as an Acadia executive put it — while obscuring their involvement now that their own names have been tarnished by lawsuits and government settlements. Read more. By Tara Bannow |
|
 Anthony Tieuli for STAT
Medicaid is paying millions for salty, fat-laden 'medically tailored' cheeseburgers and sandwiches They're marketed as healthy, "dietitian-approved" meals and delivered directly to the homes of people seriously ill from cancer, diabetes, or heart disease: a Jimmy Dean frozen sausage breakfast sandwich, biscuits and gravy, a cheeseburger. These are among the offerings sold by an Idaho-based company, Homestyle Direct, which is paid millions of dollars each year by taxpayer-funded state Medicaid programs to deliver what the company calls medically tailored meals. Read more. By Nicholas Florko
 Jovelle Tamayo for STAT
The untold story of the Human Genome Project: How one man's DNA became a pillar of genetics Undark's review of more than 100 emails, letters, and other digital documents reveals that the project's sourcing of human genetic material was more ethically fraught than official publications portrayed it to be, and included DNA harvested from a cadaver, and from one of the project's own scientists. Read more. By Ashley Smart — Undark
More great reads from STAT this week |
|
Check out more exclusive coverage with a STAT+ subscription | Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles. |
|
| STAT, 1 Exchange Place, Boston, MA | ©2024, All Rights Reserved. | |
|
No comments